UnitLevel 3Undergraduate

PHR3141 Comprehensive Care: Pathogens, host defence and treatment

Faculty of Pharmacy and Pharmaceutical Sciences

PHR3141 Comprehensive Care: Pathogens, host defence and treatment is a level 3, 12-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2020 in Semester 1 at Malaysia and Parkville. It needs PHR2041, PHR2142, PHR2011, PHR2141, PHR1022, PHR2012, PHR2021, PHR2042, PHR1031, PHR1012, PHR1011 and PHR1021 and unlocks 9 units.

Credit points
12
Offered in 2020
Semester 1
Malaysia, Parkville

This is the 2020 handbook entry. See the 2027 entry.

Reviews

No reviews yet

No reviews yet. Be the first to review PHR3141.

Requisites

Overview

This unit provides the knowledge and skills required for the diagnosis and therapeutic management of patients with selected infectious diseases. The unit will cover bacterial, viral, and fungal infections as well as antimicrobial stewardship. Students will relate the pathophysiology and epidemiology of these conditions to the rational design and clinical use of medicines. The chemistry, pharmacology, disposition, and clinical and therapeutic aspects of medicines associated with each condition will be explored in an integrated fashion. This unit will involve the development of pharmacy relevant skills such as therapeutic reasoning and, oral and written communication skills. Quality use of medicines for treating infectious diseases will be emphasised, enabling students to acquire the skills necessary to optimise patient outcomes in different cultural settings.

Offerings in 2020

Teaching periodCampusMode
First semesterMalaysiaOn campus
First semesterParkvilleOn campus

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Describe fundamental concepts of microbiology and host defence mechanisms including immunology and microorganism classification and apply these concepts to the treatment and prevention of infectious diseases.

  2. 2

    Describe the epidemiology and clinical aspects of infectious disease state management for selected bacterial and viral infections including respiratory, skin and soft tissue, and urinary tract infections, sexually transmitted infections, hepatitis, the human immunodeficiency virus and associated opportunistic infections

  3. 3

    Describe the signs and symptoms, and diagnostic methods relevant to a variety of infectious diseases

  4. 4

    Describe the molecular basis of drug action together with some key chemical and biological principles behind the development of medicines used to treat infectious diseases

  5. 5

    Explain the mechanism of action of drugs used in treatment of infectious diseases, and predict how this leads to the treatment of disease, possible side effects and drug resistance

  6. 6

    In the context of a pharmacist and a standardised approach to patient centred care (e.g. Monash Model of CARE) in patients' with an infectious disease: 
    (i) Gather and integrate information concerning the chemistry and pharmacology of medicines, in addition to pharmacokinetic and patient specific factors, to identify potential management options 
    (ii) Create a medication management plan which incorporates established clinical guidelines, antimicrobial stewardship principles and a comprehensive clinical review of their medicine-related problems.
    (iii) List and prioritise drug and non-drug management options for treatment and prevention
    (iv) Evaluate and justify when referral for medical assessment is required, with a particular emphasis on symptoms indicative of referral
    (v) Develop, apply and communicate education strategies that provide support and optimise patient-centred relationships and outcomes

  7. 7

    Reflect on the development and implementation of the Monash model of CARE plan and the development of other skills relevant to pharmacy practice

  8. 8

    Using principles of antimicrobial use, apply and articulate antimicrobial stewardship practices to optimise antimicrobial prescribing in multidisciplinary healthcare teams.

  9. 9

    Demonstrate proficiency in simulated clinical settings by applying clinical reasoning and collaborative decision making to communicate a medication management plan that optimises patient health outcomes

Workload and teaching

  • One hundred and forty-four hours of independent study
  • Forty-eight hours of pre-learning activities (up to 4 hours per week)
  • Forty-eight hours of active learning lectures (4 hours a week)
  • Forty-eight hours of small group classes including assessment (4 hours per week)
  • Two 130 minute written examinations

Contacts

Unit Coordinators
Ms Alana Meaklim
Dr Ali Blebil
Chief Examiners
Dr Suzanne Caliph

Common questions

What are the prerequisites for PHR3141?

You need PHR2041, PHR2142, PHR2011, PHR2141, PHR1022, PHR2012, PHR2021, PHR2042, PHR1031, PHR1012, PHR1011 and PHR1021 before you enrol.

What can I take after PHR3141?

PHR3141 is a prerequisite or corequisite for 9 units, including PHR1101, PHR3042, PHR3062, PHR4012, PHR4042 and PHR4061.

When is PHR3141 offered?

In 2020, PHR3141 runs in Semester 1 at Malaysia and Parkville.

More details

Credit points
12
Level
3
Study level
Undergraduate
Faculty
Faculty of Pharmacy and Pharmaceutical Sciences
Type
Coursework
EFTSL
0.250
Student contribution
SCA Band 2
Study abroad
Not available